Biogen stock rockets to 6-year high after Alzheimer’s drug gets FDA OK
June 07, 2021 at 16:13 PM EDT
Shares of Biogen Inc. rocketed to a six-year high in volatile trading Monday, as Wall Street analysts cheered the U.S. Food and Drug Administration's broad labeling that came with the approval of the biotechnology company's Alzheimer's drug.
